Residues val254, his256, and phe259 of the angiotensin ii at1 receptor are not involved in ligand binding but participate in signal transduction

Molecular Endocrinology

Volumn 12, Issue 6, 1998, Pages 810-814

  Han, H M C B ^a   Shimuta, S I ^a   Kanashiro, C A ^a   Oliveira, L ^a   Han, S W ^a   Paiva, A C M ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; HISTIDINE; IMIDAZOLE; INOSITOL PHOSPHATE; LIGAND; PHENYLALANINE; VALINE; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; HYBRID PROTEIN;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; FEMALE; GENE TRANSFER; GENETIC TRANSFECTION; HAMSTER; LIGAND BINDING; NONHUMAN; OVARY CELL; POINT MUTATION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; ANIMAL; CHEMISTRY; CHO CELL; CRICETULUS; HUMAN; METABOLISM; PHYSIOLOGY; PROTEIN BINDING; RAT; SITE DIRECTED MUTAGENESIS; STRUCTURE ACTIVITY RELATION;

ANGIOTENSIN II; ANIMALS; CHO CELLS; CRICETINAE; CRICETULUS; GTP-BINDING PROTEINS; HISTIDINE; HUMANS; INOSITOL PHOSPHATES; LIGANDS; MUTAGENESIS, SITE-DIRECTED; PHENYLALANINE; PROTEIN BINDING; RATS; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSFECTION; VALINE;

EID: 0032216550     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.12.6.0127     Document Type: Article

References (24)

1. Structure-activity relationships of peptide angiotensin II receptor agonists and antagonists
2. Analogs of angiotensin II. II. Mechanism of receptor interaction
3. New specific angiotensin antagonists: 8-Valine-, 8-isoleucine-, and chlorambucil-des-1-aspartic, 8-valine-angiotensins I
4. A common step for signal transduction in G protein-coupled receptors
5. Identification of peptide binding residues in the extracellular domains of the AT1 receptor
6. Mutagenesis and the molecular modeling of the rat angiotensin II receptor (AT)
7. Tetrazole and carboxylate groups of angiotensin receptor antagonists bind to the same subsite by different mechanisms
8. The docking of Arg2 of angiotensin II with Asp281 of AT1 receptor is essential for full agonism
9. Mutation of Asn111 in the third transmembrane domain of the AT1A angiotensin II receptor induces its constitutive activation
10. Polar residues in the transmembrane domains of the type 1 angiotensin II receptor are required for binding and coupling reconstitution of the binding site by co-expression of two deficient mutants
11. Interaction of Phe8 of angiotensin II with Lys199 and His256 of AT1 receptor in agonist activation
12. Dual agonistic and antagonistic property of nonpeptide angiotensin AT1 ligands: Susceptibility to receptor mutations
13. A review of mutagenesis studies of angiotensin II type 1 receptor, the three-dimensional receptor model in search of the agonist and antagonist binding site and the hypothesis of a receptor activation mechanism
14. The ligand binding site of the angiotensin AT1 receptor
15. A computer modeling postulated mechanism for angiotensin II receptor activation
16. Differentiation between binding sites for angiotensin II and nonpeptide antagonists on the angiotensin II type 1 receptors
17. Low-barrier hydrogen bond and enzymic catalysis
18. A new solid-state reagent to iodinate proteins
19. Epitope tagging and immunoreactivity of the human angiotensin II type 1 receptor
20. DNA sequencing with chain-terminating inhibitors
21. Rapid accumulation of inositol trisphosphate reveals that agonists hydrolyse polyphosphoinositides instead of phosphatidylinositol
22. Statistical estimation in enzyme kinetics
23. What If: A molecular modeling and drug design program
24. Model for the structure of bacteriorhodopsin based on high-resolution electron cryo-microscopy